Research News

Vaccination remains the first line of defense against COVID-19 for those who live with spondyloarthritis (SpA)...

Meeting in person for the first time since the start of the pandemic, the 2022 SPARTAN conference featured…

Upadacitinib is approved for the treatment of adults with active AS who…

In a study led by researchers at Columbia University Mailman School of…

The subclass of medications called biosimilars has been getting increased…

Not all people with axSpA, despite having the same inflammation and symptoms…